HOME > BRAND

Samsung Biologics 2022 net income up 102.8 pct to 798.1 bln won

영문경제 / 2023-01-27 15:40:51
  • facebookfacebook
  • twittertwitter
  • kakaokakao
  • pinterestpinterest
  • navernaver
  • bandband
  • -
  • +
  • print
Samsung Biologics-2022 earnings

Samsung Biologics-2022 earnings

Samsung Biologics 2022 net income up 102.8 pct to 798.1 bln won

SEOUL, Jan. 27 (Yonhap) -- Samsung Biologics Co. on Friday reported its 2022 net income of 798.1 billion won (US$648.1 million), up 102.8 percent from a year earlier.

The company said in a regulatory filing that operating profit for the year rose 83.1 percent on-year to 983.6 billion won. Annual revenue increased 91.4 percent to 3 trillion won.

(END)

(C) Yonhap News Agency. All Rights Reserved

[관련기사]

Thom Browne to set up new company in Korea2023.01.28

LATEST ARTICLES

Tried Korea's notoriously difficult 2026 English Suneung (College entrance exam)

Tried Korea's notoriously difficult 2026 English Suneung (College entrance exam)